Senior vice president and chief strategy officer,
In addition to his role at Intermountain, Liljenquist serves as board chairman for Civica Rx, the not-for-profit generic drug company founded in 2018 by Intermountain and other U.S. health systems. He has worked with leadership to expand Civica Rx’s membership, recently adding Anthem and the Blue Cross Blue Shield Association to the mix. At Intermountain, as the pandemic was hitting full stride, Liljenquist helped launch Project Protect, a program to manufacture medical-grade personal protective equipment for front-line workers. The project resulted in 6 million masks being made, exceeding the goal by 20%, as well as 100,000 face shields and 60,000 isolation gowns. The project was a finalist in Fast Company’s annual World Changing Ideas Awards.